Effect of the rapid‐acting insulin analogue insulin aspart on quality of life and treatment satisfaction in patients with Type 1 diabetes

Bott, U.; H Ebrahim, Susanne; Hirschberger, S.; Skovlund, Søren

doi:10.1046/j.1464-5491.2003.01010.x

Public

Effect of the rapid‐acting insulin analogue insulin aspart on quality of life and treatment satisfaction in patients with Type 1 diabetes

Published in Diabetic Medicine • Jul 21, 2003

Authors:

U. Bott

Susanne H Ebrahim

S. Hirschberger

Abstract

AIMS: To compare quality of life (QoL) and treatment satisfaction in patients with Type 1 diabetes receiving the rapid-acting insulin analogue, insulin aspart (IAsp), with that in patients receiving soluble human insulin (HI). METHODS: In this 6-month, multinational, randomized, open-label trial, 42...

View

Paywalled

Subject

Medicine

Insulin

Type 2 diabetes

Generate AI Take for this paper

Highlights, strengths & weaknesses, commercial applications, and societal impact — written for this paper on demand.

Subject

Generate AI Take for this paper

Discussions